Embedded Files
Who We Are
TissueGenix is a biotech located in San Diego, California.
We are a team with interdisciplinary talents pioneering in human tissue modeling, cell biology, and 3D bioprinting.
Our Co-Founder Dr. Shaochen Chen and Scientific Foundation
TissueGenix ’s precision 3D tissue platforms are the result of decades of groundbreaking research and development from the lab of our co-founder, Dr. Shaochen Chen, at the University of California, San Diego. As a world authority and pioneer in bioprinting and tissue engineering, Dr. Chen's work has been instrumental in creating tissue models recapitulating human biology and disease phenotypes. Our proprietary 3D bioprinting approach supports scalable production of human tissue models across programs, enabling expansion across indications and modalities with high adaptability to existing platforms.
Our Value
Human Relevance
Precision & Reproducibility
Practical Adoption
Operational Efficiency
Our Mission
Aligned with the shift toward human-based research technologies, we enable human-based preclinical research by generating precision 3D human tissues compatible with standard multiwell plates, while keeping iteration cycles short and cost efficiency.
Our Mission Aligns with Regulatory Policy
In 2025, the FDA announced a plan to reduce and potentially replace certain animal testing requirements in defined contexts by encouraging NAMs, including advanced human tissue/organ in vitro models.
At the same time, NIH has also announced an initiative to prioritize human-based research technologies and plans to establish ORIVA to coordinate validation and scaling of non-animal approaches.
TissueGenix is positioned to help pharma and biotech partners navigate this shift with practical, plate-compatible 3D human tissue systems for screening and research purposes
Page updated
Google Sites
Report abuse